Pharma

Boehringer Ingelheim booth at AACR 2026
Marketing

Boehringer again rises up rare disease reputation rankings

Despite back-to-back jumps, the German drugmaker failed to crack the top three of the full table, which the same three companies occupied again.
Nick Paul Taylor Aug 20, 2026 4:29am
An artists impression of DNA The DNA appears to be made up of glowing orbs and appears on a blue background

Ultragenyx, after FDA speed bump, lands 1st gene therapy nod

Aug 19, 2026 10:33pm
video
Beyond an Agency How AI Creativity and Commercialization Are Converging Into a New Growth Model

How AI, Creativity and Commercialization Are Converging

Brought to you by EVERSANA INTOUCH
Regeneron

Pasatru approved by FDA as 2nd drug for rare bone lesion disease

Aug 19, 2026 2:35pm
Podcast
Top Line Podcast - ZS

Designing an agentic, future‑ready tech roadmap for emerging pharma

Brought to you by ZS
settlement

SK settles with MSN over generic of seizure med Xcopri: reports

Aug 19, 2026 11:21am